Anticoagulant pharmaceutical monitoring management method based on clinical data

A technology of clinical data and management methods, applied in the field of data monitoring and management, can solve the problems of limited monitoring level, professional level, and inability to grasp the patient's treatment process, curative effect and whether adverse reactions occur at any time

Active Publication Date: 2020-05-29
成都木老仁康软件信息有限公司
View PDF8 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Clinical pharmacists use manual methods to judge which patients need to receive anticoagulant pharmaceutical care after reviewing various clinical diagnosis and treatment information of patients and combining with the consensus of anticoagulant-related clinical guidelines; In changing conditions, clinical pharmacists cannot keep track of each patient's treatment process, curative effect and whether adverse reactions occur; clinical pharmaci

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anticoagulant pharmaceutical monitoring management method based on clinical data

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0050] The present invention will be described in detail below in conjunction with the accompanying drawings, and the technical solutions in the embodiments of the present invention will be clearly and completely described. Apparently, the described embodiments are only some, not all, embodiments of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.

[0051] The present invention provides an anticoagulant pharmaceutical monitoring information method based on clinical data through improvement, including:

[0052] (1) Clinical data collection and processing:

[0053] Collect all clinical information data of patients distributed in various medical business information systems in quasi-real time, and perform data cleaning and conversion, normalization processing, and data integration and data storage ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an anticoagulant pharmaceutical monitoring management method based on clinical data. The method is characterized by comprising the following steps: step 1, realizing clinical data acquisition and processing; step 2, realizing group entry evaluation of monitored patients; and step 3, realizing active monitoring and real-time early warning. Patients needing to be subjected toanticoagulation pharmaceutical monitoring can be automatically brought into pharmaceutical monitoring, and automatic, intelligent and active monitoring and real-time early warning are conducted on the monitored patients according to a monitoring early warning model. Therefore, the anticoagulation treatment effect is greatly improved, serious adverse events such as bleeding and stroke are reduced;meanwhile, the anticoagulation pharmacy monitoring work efficiency of clinical pharmacists is greatly improved.

Description

technical field [0001] The invention relates to the related fields of data monitoring and management, in particular to an anticoagulant pharmaceutical monitoring and management method based on clinical data. Background technique [0002] Anticoagulant therapy is the most important means of clinical prevention and treatment of thromboembolism, atrial fibrillation, venous thromboembolism (VTE), heart valve disease, artificial valve replacement, and the prevention of new and recurrent ischemic stroke. effective method. A number of large-scale clinical studies have confirmed that anticoagulant therapy and monitoring intervention can significantly reduce the incidence of ischemic stroke in patients with atrial fibrillation and effectively improve the prognosis. Statistics show that the incidence of stroke in patients with atrial fibrillation in my country is as high as 24.8%. Atrial fibrillation increases the risk of ischemic stroke and systemic arterial embolism, with annual i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G16H20/13G16H10/20G16H10/60G16H50/30G16H50/70G16H70/40
CPCG16H20/13G16H10/20G16H10/60G16H50/30G16H50/70G16H70/40Y02A90/10
Inventor 乐杰
Owner 成都木老仁康软件信息有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap